Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-23-008936

Global President TAVR & Surg sold 8,660 shares at $73.63 ($637,615)

  • Global President TAVR & Surg acquired 8,660 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wood Larry L · Global President TAVR & Surg

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-09-14 Exercise or conversion : show line 1 in the form 10b5-1 +8,660 $45.28 $392,096 222,453.71 D
2023-09-14 Sale : show line 2 in the form 10b5-1 −8,660 $73.63 $637,615 213,793.71 D
Open-market sales · 8,660 sh · avg $73.63 · $637,615

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2023-09-14 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −8,660 $45.28 2025-05-16 8,660 25,978 D
Loading xslF345X05/doc4.xml…